Author Topic: Morality of Covid Vaccine (from a priest friend)  (Read 1370 times)

Offline Christe Eleison

  • Mary Garden
  • Feldwebel
  • ***
  • Posts: 2331
  • Thanked: 2370 times
  • Religion: Catholic
Morality of Covid Vaccine (from a priest friend) Thanks, MICHAEL WILSON!:)
« Reply #15 on: September 28, 2021, 07:54:21 PM »
The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro

Abstract

Although several clinical trials are now underway to test possible therapies, the worldwide response to the COVID-19 outbreak has been largely limited to monitoring/containment. We report here that Ivermectin, an FDA-approved anti-parasitic previously shown to have broad-spectrum anti-viral activity in vitro, is an inhibitor of the causative virus (SARS-CoV-2), with a single addition to Vero-hSLAM cells 2 h post infection with SARS-CoV-2 able to effect ~5000-fold reduction in viral RNA at 48 h. Ivermectin therefore warrants further investigation for possible benefits in humans.

https://pubmed.ncbi.nlm.nih.gov/32251768/
 
The following users thanked this post: Lynne, Michael Wilson, ChairmanJoeAintMyPrez

Offline ChairmanJoeAintMyPrez

  • Korporal
  • **
  • Posts: 462
  • Thanked: 792 times
  • LET'S GO BRANDON!
  • Religion: Catholic
Re: Morality of Covid Vaccine (from a priest friend)
« Reply #16 on: September 28, 2021, 08:26:35 PM »
Supposedly, Merck Pharmaceutical, the original producer of Ivermectin,
as well as Pfizer will be coming out with some sort of drug/pill that will
contain IVERMECTIN.

Of course, they will add something else, maybe Vitamin C :rolleyes: or Zinc,
or whatever. To be able to patent it.
And charge thousands of Dollars compared to the pennies that Ivermectin costs. 

The key issue is that Ivermectin is OFF patent & inexpensive. Follow the money.

Ivermectin has been used for years by the Military when they go on missions, to prevent malaria. It is SAFE!

I've heard two versions of this story - in one, they're reformulating Ivermectin along with something else so that they can patent it.  In the other, they're developing a new protease inhibitor.  (That's the same mechanism of action by which Ivermectin slows/stops viral replication.)

Both stories are believable.  Both stories are things that drug megacorps have been known to do in the past.  In either case, it'll do the same thing as everyone's favorite horse paste, except the "new" drug is patentable.
 
The following users thanked this post: Lynne, Michael Wilson, Christe Eleison

Offline Christe Eleison

  • Mary Garden
  • Feldwebel
  • ***
  • Posts: 2331
  • Thanked: 2370 times
  • Religion: Catholic
Merck Pill Molnupiravir- Morality of Covid Vaccine (from a priest friend)
« Reply #17 on: October 02, 2021, 10:54:04 PM »
Supposedly, Merck Pharmaceutical, the original producer of Ivermectin,
as well as Pfizer will be coming out with some sort of drug/pill that will
contain IVERMECTIN.

Of course, they will add something else, maybe Vitamin C :rolleyes: or Zinc,
or whatever. To be able to patent it.
And charge thousands of Dollars compared to the pennies that Ivermectin costs. 

The key issue is that Ivermectin is OFF patent & inexpensive. Follow the money.

Ivermectin has been used for years by the Military when they go on missions, to prevent malaria. It is SAFE!

Merck and Ridgeback Biotherapeutics announced on Friday early result that indicate their experimental oral antiviral drug molnupiravir

In a news release, the company said 7.3% of 385 patients who received the antiviral were either hospitalized or died from Covid-19, compared with 14.1% of the 377 patients who received a placebo, which does nothing.

Full data from the molnupiravir trial has not yet been released, and this data has not yet been peer-reviewed or published. But Merck says it will seek authorization from the US Food and Drug Administration, and if it's granted, the drug could be
the first antiviral treatment available orally to fight COVID 19.


"This is the most impactful result that I remember seeing of an orally available drug in the treatment of a respiratory pathogen, perhaps ever," Dr. Scott Gottlieb, former commissioner of the US Food and Drug Administration stated"
"I think getting an oral pill that can inhibit viral replication -- that can inhibit this virus -- is going to be a real game changer."

Antiviral treatments are a type of antimicrobial -- treatments which kill or otherwise inhibit the development of microorganisms such as bacteria (fought by antibiotics), fungi (fought by antifungals), or, in this case, a virus.

Some of the more familiar antivirals are those developed to treat herpes, HIV and the flu.

"Most people have heard of Tamiflu, and they've heard of acyclovir," said Dr. Myron Cohen, a professor of medicine, microbiology, immunology and epidemiology at the University of North Carolina. Acyclovir is a type of antiviral used to treat chickenpox, herpes and shingles.

"We didn't develop a ton of other antivirals," he said.

What makes molnupiravir different.

Another antiviral, remdesivir, is currently the only drug approved by the FDA for the treatment of Covid-19. Remdesivir, which is made by Gilead Sciences and sold under the name Veklury, is administered by intravenous infusion, so it's not as simple as swallowing a pill.

And remdesivir doesn't work for all Covid-19 patients. Studies have shown mixed results; it doesn't seem to reduce the risk of death, but it does seem to help people feel better faster, when it's given early in an illness.

The National Institutes of Health's Covid-19 treatment guidelines recommend remdesivir for hospitalized Covid-19 patients who need supplemental oxygen, but the World Health Organization recommends against using it outside of clinical trials.

Molnupiravir would be simpler for patients -- no IV required -- and it works differently, by changing the SARS-CoV-2 virus to inhibit replication.

"It actually gets incorporated into the genetic material of the of the virus and introduces errors," Dr. Daria Hazuda, chief science officer with MSD, Merck's label operating outside of the US and Canada, said in a briefing with the Science Media Center in the UK on Friday.

"So, over a number of incorporations, the errors make the virus less able to replicate."

Dr. Mark Denison, a virologist at the Vanderbilt Institute for Infection, Immunology, and Inflammation, said the way molnupiravir works, called mutagenesis, is what separates it from remdesivir.

"The two basic mechanisms are either chain termination, which I call the delayed stop sign, or mutagenesis, which is like blowing potholes in the road as the car is driving along. It's just damaging the genome,"

What an antiviral pill could mean for Covid-19

Cohen, who has previously worked on molnupiravir, said when looking at results for an antiviral drug like molnupiravir, he wants to see three things.

"Stop progression of disease, so you take them and you forget about it, right?" he said. "The second thing we'd like the pill to do, if you're taking it for symptomatic disease, is stop long Covid, right? It's not just 'Don't let me get progressed and die -- don't let me have lingering cough, lingering headache.' "

Cohen said his third goal would be for "treatment to serve as prevention," so someone with Covid-19 is less likely to transmit it to others.

"We'd like it to wipe out the SARS-CoV-2 replication in the nose so fast that your nose is no longer a danger to me," he said.

"We already have monoclonal antibodies that do this and actually are pretty effective. The problem is they require an infusion or injections. That's really burdensome for the individual, that's burdensome on the health care system," she said, referring to Covid-19 treatments made by Regeneron, Eli Lilly and GlaxoSmithKline and Vir.

"It would be a total game changer if somebody, when they're diagnosed with mild Covid, early on in their treatment are able to take a pill at home. That relieves the burden on the health care system. That also really helps the individual."

Still, an antiviral can't replace a vaccine.  :(

White House Covid-19 Response Coordinator Jeff Zients said during a briefing on Friday that the best way to think of such a drug is as an additional tool, to be used alongside vaccines.

"This is a potential additional tool in our toolbox to protect people from the worst outcomes of Covid," Zients said. "I think it's really important to remember that vaccination, as we've talked about today, remains far and away our best tool against Covid-19. It can prevent you from getting Covid in the first place. And we want to prevent infections, not just wait to treat them once they happen."

What's next for molnupiravir.

There's still a lot to learn about the drug and who it might work for. The trial detailed Friday focused on adult patients who were considered high-risk for severe Covid-19, most commonly because of obesity, older age, diabetes and heart disease. None had been vaccinated against Covid-19.

Molnupiravir is also being studied as post-exposure prophylaxis -- researchers are looking at whether it can prevent spread of the virus within households, after someone has been exposed but hasn't yet tested positive.

Merck said Friday is plans to submit an application to the FDA for emergency use authorization as soon as possible, and to other regulatory bodies around the world.

In anticipation of the trial results, the company said it has been producing molnupiravir at risk, and expects to have 10 million treatment courses available by the end of the year.

Merck has already sold 1.7 million treatment courses to the US government, if it gets authorization or approval from the FDA. The company said it will offer tiered pricing to provide access around the world, and will work with generic drug manufacturers to speed availability to low- and middle-income countries.

https://www.idsociety.org/covid-19-real-time-learning-network/therapeutics-and-interventions/remdesivir/
 
The following users thanked this post: ChairmanJoeAintMyPrez

Offline Christe Eleison

  • Mary Garden
  • Feldwebel
  • ***
  • Posts: 2331
  • Thanked: 2370 times
  • Religion: Catholic
MERCK PILL-Molnupiravir-PubMed NCBI NIH-Morality of Covid Vaccine Priest
« Reply #18 on: October 02, 2021, 10:54:31 PM »
Supposedly, Merck Pharmaceutical, the original producer of Ivermectin,
as well as Pfizer will be coming out with some sort of drug/pill that will
contain IVERMECTIN.

Of course, they will add something else, maybe Vitamin C :rolleyes: or Zinc,
or whatever. To be able to patent it.
And charge thousands of Dollars compared to the pennies that Ivermectin costs. 

The key issue is that Ivermectin is OFF patent & inexpensive. Follow the money.

Ivermectin has been used for years by the Military when they go on missions, to prevent malaria. It is SAFE!

Merck's Molnupiravir Pill

Abstract

Background:

Easily distributed oral antivirals are urgently needed to treat coronavirus disease-2019 (COVID-19), prevent progression to severe illness, and block transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We report the results of a Phase 2a trial evaluating the safety, tolerability, and antiviral efficacy of molnupiravir in the treatment of COVID-19
( ClinicalTrials.gov NCT04405570 ).

Methods:

Eligible participants included outpatients with confirmed SARS-CoV-2 infection and symptom onset within 7 days. Participants were randomized 1:1 to 200 mg molnupiravir or placebo, or 3:1 to molnupiravir (400 or 800 mg) or placebo, twice-daily for 5 days. Antiviral activity was assessed as time to undetectable levels of viral RNA by reverse transcriptase polymerase chain reaction and time to elimination of infectious virus isolation from nasopharyngeal swabs.

Results:

Among 202 treated participants, virus isolation was significantly lower in participants receiving 800 mg molnupiravir (1.9%) versus placebo (16.7%) at Day 3 (p = 0.02). At Day 5, virus was not isolated from any participants receiving 400 or 800 mg molnupiravir, versus 11.1% of those receiving placebo (p = 0.03). Time to viral RNA clearance was decreased and a greater proportion overall achieved clearance in participants administered 800 mg molnupiravir versus placebo (p = 0.01). Molnupiravir was generally well tolerated, with similar numbers of adverse events across all groups.

Conclusions:

Molnupiravir is the first oral, direct-acting antiviral shown to be highly effective at reducing nasopharyngeal SARS-CoV-2 infectious virus and viral RNA and has a favorable safety and tolerability profile.

https://pubmed.ncbi.nlm.nih.gov/34159342/
 
The following users thanked this post: ChairmanJoeAintMyPrez

Offline Christe Eleison

  • Mary Garden
  • Feldwebel
  • ***
  • Posts: 2331
  • Thanked: 2370 times
  • Religion: Catholic
Merck's PILL & more- Morality of Covid Vaccine (from a priest friend)
« Reply #19 on: October 03, 2021, 03:23:24 AM »
Merck’s stock gained 9.1% in trading on Friday after announcing that the drug, molnupiravir, cut the risk of hospitalization or death by 50% in a Phase 3 clinical trial. (Ridgeback is privately held.)

Merck and Ridgeback Therapeutics Inc.’s promising oral antiviral could shift the direction of the pandemic by making it easier for people with COVID-19 to take a pill at home that can keep them from getting severely sick.

The drug, which inhibits replication of the virus, was tested in 775 “at-risk” adults with mild or moderate cases of COVID-19. No one taking the drug died in the trial; eight deaths were reported among those taking the placebo.

It also appeared to work against the gamma, delta, and mu variants in the roughly 40% of participants for whom sequencing was available.

“It’s a very big deal,” Dr. Eric Topol, director of the Scripps Research Translational Institute, said in an email. “If safe and inexpensive (even freely available) as a pill that is easily taken, it could have enormous benefit for reducing severe illness, for both unvaccinated and breakthrough vaccinated people.”

The U.S. has already ordered 1.7 million treatment courses of molnupiravir at a price of about $705 for each five-day course of treatment.

Other COVID-19 antivirals in development

There are half a dozen oral antiviral drugs in development right now, spurred by a $3 billion investment from the National Institutes of Health into COVID-19 antiviral development back in June.

Pfizer Inc. already a pandemic favorite for its role developing Comirnaty, the first authorized and approved COVID-19 vaccine in the U.S., is expected to have late-stage clinical data for its investigational antiviral pill before the end of the year.

Several other small drug makers and biotechs are also testing antivirals as COVID-19 treatments, including Adamis Pharmaceuticals Corp. Atea Pharmaceuticals Inc. and RedHill Biopharma Ltd. Gilead has also been studying Veklury as a treatment for high-risk COVID-19 patients who have not been hospitalized.

Merck said Friday it plans to soon submit the data for emergency authorization.

Merck’s stock is down 3.7% for the year, while the broader S&P 500 is up 14.7%.
 
The following users thanked this post: Michael Wilson, ChairmanJoeAintMyPrez

Offline Christe Eleison

  • Mary Garden
  • Feldwebel
  • ***
  • Posts: 2331
  • Thanked: 2370 times
  • Religion: Catholic
Pfizer Pill-Zero Hedge- Morality of Covid Vaccine (from a priest friend)
« Reply #20 on: October 03, 2021, 06:40:47 AM »
https://www.zerohedge.com/covid-19/pfizer-launches-final-study-covid-drug-thats-suspiciously-similar-ivermectin

Pfizer Launches Final Study For COVID Drug That's Suspiciously Similar To 'Horse Paste'

Another piece US anti-Ivermectin puzzle may have emerged. On Monday, Pfizer announced that it's launching an accelerated Phase 2/3 trial for a COVID prophylactic pill designed to ward off COVID in those may have come in contact with the disease.

Coincidentally (or not), Pfizer's drug shares at least one mechanism of action as Ivermectin - an anti-parasitic used in humans for decades, which functions as a protease inhibitor against Covid-19, which researchers speculate "could be the biophysical basis behind its antiviral efficiency."

Lo and behold, Pfizer's new drug - which some have jokingly dubbed "Pfizermectin," is described by the pharmaceutical giant as a "potent protease inhibitor."

As Zero Hedge readers might recognize, that's exactly what ivermectin, the prophylactic used for a number of reasons in both humans and animals, does. And unlike Pfizer's experimental drug, ivermectin already may have saved hundreds of thousands of lives from India to Brazil.

We aren't the only ones to have put this together, as twitter users have commented on the similarities. The timing - which coincides with the whole "horse dewormer" smear campaign - just seems odd.

The similarity between Pfizer's upcoming offering and Ivermectin has not gone unnoticed.

But Pfizer, Moderna and their executives have already shown the world with their actions that they see COVID as "manna from heaven" - to quote legendary defense attorney Johnny Cochran -  a new 'profit center' that will keep shareholders in butter brickle, especially since the companies have quietly raised prices on their vaccines.

But since a large portion of the American market has rejected the vaccines, Pfizer needs another medication that can be used to treat them as well (otherwise, the company is missing out on nearly one-third of the American market).

According to Reuters, Pfizer said on Monday it has "started a large study testing its investigational oral antiviral drug for the prevention of COVID-19 infection among those who have been exposed to the virus."

Pfizer isn't the only drugmaker hoping to develop a prophylactic treatment for COVID exposure (especially since variants raise the possibility that vaccinations just might not be enough). Merck and Swiss rival Roche have been racing to develop an easy-to-administer antiviral pill of their own - so the clock is ticking for Pfizer.

Reuters explains that the mid-to-late-stage study will test the Pfizer drug's - known as PF-07321332 ability to prevent COVID symptoms in up to 2,660 healthy adult participants aged 18 and older who live in the same household as an individual with a confirmed symptomatic COVID infection.

The drug, designed to block the activity of a key enzyme needed for the coronavirus to multiply inside the human body, will be administered along with a low dose of ritonavir, an older medication widely used in combination treatments for HIV infection.

At present, Gilead's much-hyped but not-all-that-effective IV drug remdesivir is the only approved antiviral treatment for COVID in the US. Several antibody cocktails have also been widely tested and trials are ongoing - including Merck and partner Ridgeback Biotherapeutics, which recently launched a late-stage trial for experimental COVID prophylactic, molnupiravir.

In the mean time, concerned citizens should keep an eye out for any new information about Ivermectin - if you can find it.


Reuters Science News
@ReutersScience
Replying to @ReutersScience
The mid-to-late-stage study will test Pfizer's drug, PF-07321332, in
up to 2,660 healthy adult participants aged 18 and older who live in the same household as an individual with a confirmed symptomatic COVID-19 infection 2/4
 
The following users thanked this post: Michael Wilson, ChairmanJoeAintMyPrez

Offline Christe Eleison

  • Mary Garden
  • Feldwebel
  • ***
  • Posts: 2331
  • Thanked: 2370 times
  • Religion: Catholic
Covid-19 Criminal History- Morality of Covid Vaccine (from a priest friend)
« Reply #21 on: October 03, 2021, 06:50:28 AM »
One of the comments from the above article ^^^^

COVID-19 Criminal Conspiracy:

The vaccine and the virus were made by the same people.

In 2014, there was a moratorium on SARS gain-of-function research that lasted until 2017. This research was not halted. Instead, it was outsourced, with the federal grants being laundered through NGOs.

Ralph Baric is a virologist and SARS expert at UNC Chapel Hill in North Carolina. This is who Anthony Fauci was referring to when he insisted, before Congress, that if any gain-of-function research was being conducted, it was being conducted in North Carolina.

A lie: Anthony Fauci lied before Congress. A felony.

Ralph Baric and Shi Zhengli are colleagues and have co-written papers together. Ralph Baric mentored Shi Zhengli in his gain-of-function manipulation techniques, particularly serial passage, which results in a virus that appears as if it originated naturally. In other words, deniable bioweapons. Serial passage in humanized hACE2 mice may have produced something like SARS-CoV-2.

The funding for the gain-of-function research being conducted at the Wuhan Institute of Virology came from Peter Daszak. Peter Daszak runs an NGO called EcoHealth Alliance. EcoHealth Alliance received millions of dollars in grant money from the National Institutes of Health/National Institute of Allergy and Infectious Diseases (that is, Anthony Fauci), the Defense Threat Reduction Agency (part of the US Department of Defense), and the United States Agency for International Development. NIH/NIAID contributed a few million dollars, and DTRA and USAID each contributed tens of millions of dollars towards this research. Altogether, it was over a hundred million dollars.

EcoHealth Alliance subcontracted these grants to the Wuhan Institute of Virology, a lab in China with a very questionable safety record and poorly trained staff, so that they could conduct gain-of-function research, not in their fancy P4 lab, but in a level-2 lab where technicians wore nothing more sophisticated than perhaps a hairnet, latex gloves, and a surgical mask...

In November of 2019, three technicians at the Wuhan Institute of Virology developed symptoms consistent with a flu-like illness. Anthony Fauci, Peter Daszak, and Ralph Baric knew at once what had happened, because back channels exist between this laboratory and our scientists and officials.

December 12th, 2019, Ralph Baric signed a Material Transfer Agreement (essentially, an NDA) to receive Coronavirus mRNA vaccine-related materials co-owned by Moderna and NIH. It wasn’t until a whole month later, on January 11th, 2020, that China allegedly sent us the sequence to what would become known as SARS-CoV-2...

Stephane Bancel, the current CEO of Moderna, was formerly the CEO of bioMerieux, a French multinational corporation specializing in medical diagnostic tech, founded by one Alain Merieux,one of the individuals who was instrumental in the construction of the Wuhan Institute of Virology’s P4 lab...

This is not a conspiracy “theory”. It is an actual criminal conspiracy, in which people connected to the development of Moderna’s mRNA-1273 are directly connected to the Wuhan Institute of Virology and their gain-of-function research by very few degrees of separation, if any. The paper trail is well- established.

The lab-leak theory has been suppressed because pulling that thread leads one to inevitably conclude that there is enough circumstantial evidence to link Moderna, the NIH, the WIV, and both the vaccine and the virus’s creation together... Anthony Fauci, Peter Daszak, Ralph Baric, Shi Zhengli, and Stephane Bancel, and their accomplices, would have been indicted and prosecuted to the fullest extent of the law. Instead, billions of our tax dollars were awarded to the perpetrators.

The FBI raided Allure Medical in Shelby Township north of Detroit for billing insurance for “fraudulent COVID-19 cures”. They were using Intravenous Vitamin C, an antioxidant which, as described above, is an entirely valid treatment for COVID-19-induced sepsis, and indeed, is now part of the MATH+ protocol advanced by Dr. Paul E. Marik.

The FDA banned ranitidine (Zantac) due to supposed NDMA (N-nitrosodimethylamine) contamination. Ranitidine is not only an H2 blocker used as antacid, but also has a powerful antioxidant effect, scavenging hydroxyl radicals. This gives it utility in treating COVID-19.

The FDA also attempted to take N-acetylcysteine, a harmless amino acid supplement and antioxidant, off the shelves, compelling Amazon to remove it from their online storefront.

This leaves us with a chilling question: did the FDA knowingly suppress antioxidants useful for treating COVID-19 sepsis as part of a criminal conspiracy against the American public?

The establishment is cooperating with, and facilitating, the worst criminals in human history, and are actively suppressing non-vaccine treatments and therapies in order to compel us to inject these criminals’ products into our bodies. This is absolutely unacceptable.
 
The following users thanked this post: Michael Wilson, ChairmanJoeAintMyPrez

Offline ChairmanJoeAintMyPrez

  • Korporal
  • **
  • Posts: 462
  • Thanked: 792 times
  • LET'S GO BRANDON!
  • Religion: Catholic
Re: Pfizer Pill-Zero Hedge- Morality of Covid Vaccine (from a priest friend)
« Reply #22 on: October 03, 2021, 06:54:00 AM »
Pfizer Launches Final Study For COVID Drug That's Suspiciously Similar To 'Horse Paste'

 
The following users thanked this post: Michael Wilson, Christe Eleison

Offline diaduit

  • Mary Garden
  • Feldwebel
  • ***
  • Posts: 2738
  • Thanked: 3667 times
  • Religion: Catholic
Re: Morality of Covid Vaccine (from a priest friend)
« Reply #23 on: October 03, 2021, 08:38:05 AM »
Supposedly, Merck Pharmaceutical, the original producer of Ivermectin,
as well as Pfizer will be coming out with some sort of drug/pill that will
contain IVERMECTIN.

Of course, they will add something else, maybe Vitamin C :rolleyes: or Zinc,
or whatever. To be able to patent it.
And charge thousands of Dollars compared to the pennies that Ivermectin costs. 

The key issue is that Ivermectin is OFF patent & inexpensive. Follow the money.

Ivermectin has been used for years by the Military when they go on missions, to prevent malaria. It is SAFE!

I've heard two versions of this story - in one, they're reformulating Ivermectin along with something else so that they can patent it.  In the other, they're developing a new protease inhibitor.  (That's the same mechanism of action by which Ivermectin slows/stops viral replication.)

Both stories are believable.  Both stories are things that drug megacorps have been known to do in the past.  In either case, it'll do the same thing as everyone's favorite horse paste, except the "new" drug is patentable.

and it renders the vaccine useless and those who took the jab no longer need to argue for remote co operation.
 
The following users thanked this post: Christe Eleison, ChairmanJoeAintMyPrez